EA
INFI

Emerald Advisers’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Emerald Advisers’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-263,754
Closed -$4.6M – 369
2013
Q3 		$4.6M Sell
263,754
-31,987
-11% -$613K 0.26% 122
2013
Q2 		$4.79M Buy
+295,741
New +$9.15M 0.29% 124

Other funds holding INFI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Emerald Advisers's INFI Position: Q4 2013 in Review

Emerald Advisers sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2013, closing a stake of 263,754 shares — an estimated $4.6M sold.

Emerald Advisers first reported a position in INFI in Q2 2013 and held it in 2 quarters. The position peaked at $4.79M in Q2 2013. 104 funds tracked by Wall St. Rank hold INFI as of Q4 2013.

  • Emerald Advisers reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Emerald Advisers sold 263,754 Infinity Pharmaceuticals, Inc. shares in Q4 2013, an estimated $4.6M.
  • Emerald Advisers first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 2 quarters.
  • Emerald Advisers's Infinity Pharmaceuticals, Inc. position peaked at $4.79M in Q2 2013.
  • 104 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2013.

Based on Emerald Advisers's 13F filing for Q4 2013, filed 30 Jan 2014.